Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734312 · ClinicalTrials.gov registry record · NA
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
A NA study of Obesity and Overweight and Obesity and Obesity-related Medical Conditions, sponsored by Dr. Christopher McGowan.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT06734312 is a NA study of Obesity and Overweight and Obesity and Obesity-related Medical Conditions that is actively recruiting participants, run by Dr. Christopher McGowan. The registered enrollment target is 20 participants, below the 465-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06734312, a NA study of Obesity and Overweight and Obesity and Obesity-related Medical Conditions, is actively recruiting participants, sponsored by Dr. Christopher McGowan.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the effect of gastric fundal mucosal ablation (GFMA) on weight trajectory following discontinuation of once-weekly semaglutide or tirzepatide in adults with obesity. In this study, GFMA will be performed on patients who have experienced \> 10% weight loss with GLP-1 therapy and who plan to discontinue use of GLP-1 medications for the duration of the study.
Conditions Studied
Interventions
- DEVICE Gastric Fundal Mucosal Ablation (GFMA)
Study Locations (2)
North Carolina
- True You Weight Loss - Cary
- True You Weight Loss - Cary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06734312
The ClinicalTrials.gov registry entry for NCT06734312 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 465-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (96% lower). The listed sponsor is Dr. Christopher McGowan, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Obesity and Overweight appearing as the primary indexed condition, and to 1 intervention - of which Gastric Fundal Mucosal Ablation (GFMA) is the first listed.
NCT06734312 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06734312 about?
NCT06734312 is a clinical study titled "MAINTAIN (Mucosal AblatIoN Therapy After INcretins)". The purpose of this study is to assess the effect of gastric fundal mucosal ablation (GFMA) on weight trajectory following discontinuation of once-weekly semaglutide or tirzepatide in adults with obesity. In this study, GFMA will be performed on patients who have experienced \> 10% weight loss with ...
What is the current status of trial NCT06734312?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-01-01. Estimated completion is 2026-06.
What conditions does trial NCT06734312 study?
This clinical trial studies the following conditions: Obesity and Overweight, Obesity and Obesity-related Medical Conditions, Obesity Prevention, GLP-1, Obesity Recidivism.
What interventions are being tested in trial NCT06734312?
The interventions under investigation include: Gastric Fundal Mucosal Ablation (GFMA) (DEVICE).
Who is sponsoring clinical trial NCT06734312?
This trial is sponsored by Dr. Christopher McGowan, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06734312 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity and Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
-
Weight Management Intervention in College: A Pilot
RECRUITING · NA
-
Muscle and Movement With Anti-Obesity Medications
RECRUITING · NA
-
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients
RECRUITING · NA
Explore more on PlainTrial
Obesity and Overweight
All registered trials for this condition
Obesity and Obesity-related Medical Conditions
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.